Clinical Trial Update: Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on 6R-BH4 for coronary artery disease. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• 6R-BH4 (6R-tetrahydrobiopterin)

Snippet

Sponsor: University of Oxford | Conditions: Coronary Artery Disease | Phase 2 | Status: UNKNOWN